Sesame Care vs Breeze Meds
Two GLP-1 desks, one scoreboard. We put Sesame Care and Breeze Meds head-to-head on the published Brief Score — the same six factors, scored the same way.
Sesame Care
The verdict
Sesame Care takes this head-to-head.
Sesame Care scores 87 to 76 on our six-factor Brief Score — An established national telehealth marketplace with the widest real brand-name GLP-1 access on the board — Wegovy (pen and pill), Zepbound, Ozempic and Mounjaro — plus provider-by-provider price transparency.
That doesn't make Breeze Meds a bad call — it's best for readers starting at a low dose who want nothing charged until a provider has approved them. Weigh the six factors below against your own priorities before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.
Factor by factor
Both desks scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.
Price, coverage & the tracker
| Sesame Care | Breeze Meds | |
|---|---|---|
| Brief Score | 87/100 (B+) | 76/100 (C) |
| Semaglutide | From $149/mo (brand Wegovy pill) | From $199/mo injectable · $299/mo oral (lowest dose) |
| Tirzepatide | Brand Zepbound (price varies) | From $399/mo injectable · $399/mo oral (lowest dose) |
| Coverage | Nationwide marketplace | All 50 states |
| Brand-name access | Yes | Compounded only |
| Oral / sublingual | Yes | Yes |
| On the tracker | Stableprice stable | Stableprice stable |
Sesame Care: Marketplace pricing is set per provider rather than one desk rate; the brand-name Wegovy pill line held its ~$149 entry this cycle.
Breeze Meds: ⚠ Every published figure is quoted at the LOWEST dose — the funnel says higher doses may cost more, so these are floors.
● Not sold on either?
CoreAge Rx tops the whole board at 94/100.
The steadiest desk on the board: one flat, no-step-up price on both molecules, nationwide, and it hasn't moved.
Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.